Drug Type Polyclonal antibody |
Synonyms |
Target |
Mechanism hemagglutinin modulators(Influenza virus hemagglutinin glycoproteins modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Preclinical | CN | 29 Jan 2021 |